MSD's COVID-19 Pill Molnupiravir Gains First Approval In UK

To Be Marketed As Lagevrio

 
• By Andrew McConaghie
Merck_New_Jersey
The UK has seized the chance of being first to approve the oral COVID-19 drug, though details of how the treatment will be made available on the NHS are still being decided. • Source: Alamy

More from Business

More from Scrip